BAPM is pleased to be endorsing PReCePT – a perinatal programme reducing the incidence of cerebral palsy by offering magnesium sulphate to women during preterm labour (less than 30 weeks). For every 37 mothers who receive magnesium sulphate, one case of cerebral palsy can be prevented, improving the quality of life of preterm babies and their families. One dose of magnesium sulphate costs from just £1.
PReCePT is the first ever perinatal programme delivered at scale across England, bringing together midwives, obstetricians and neonatologists in every maternity unit in the country. The programme was originally developed by the West of England Academic Health Science Network (AHSN) in collaboration with University Hospitals Bristol NHS Foundation Trust, and involved both patients and staff. The programme is now funded by NHS England to be rolled out across the country by the AHSN Network.
